This study investigated the effectiveness and safety of adding SGLT2 inhibitors to insulin in type 1 diabetes (T1D). The authors concluded that add-on SGLT-2 inhibitor therapy may be helpful for T1D, but should be carefully considered due to potential side effects.

This study investigated the long-term glycemic (blood sugar) control of type 2 diabetes patients receiving second-line medications with or without metformin (Glucophage). This study concluded that GLP-1 receptor agonists, DPP-4 inhibitors and thiazolidinedione-based therapies offer a higher chance of long-term glycemic control compared to other treatment options.

This study investigated the effects of a low-fat vegan (plant-based) diet on pancreas function in overweight, non-diabetic adults. This study concluded that both pancreas function and insulin sensitivity significantly improved in these adults through a low-fat vegan diet.

These guidelines examined the evidence and presented recommendations for the treatment of type 2 diabetes with oral glucose-lowering drugs. It was concluded that metformin (Glucophage) was suitable for most patients, and that some may require an additional drug.

This study investigated the impact of telemonitoring and self-monitoring in the treatment and management of hypertension. They determined that self-monitoring with or without telemonitoring resulted in lower blood pressure compared to office monitoring.

This study investigated whether a systolic blood pressure (SBP) of 120 mm Hg or less is beneficial for patients with diabetes, and determined their outcomes. This study concluded that this intensive blood pressure control improves cardiovascular outcomes in those with diabetes.

This study reviewed published data to formulate guidelines on monitoring blood pressure and the risk of cardiovascular disease.

They made a number of recommendations including lowering the threshold for stage 1 and stage 2 hypertension, the use of continuous blood pressure monitoring and pharmacological treatment strategies.

This study investigated the effectiveness of different types of medication to treat salt-sensitive hypertension. The authors suggested that calcium channel blockers were the most effective class of drug in combination with hydrochlorthiazide (standard) or metformin (patients with obesity).

This phase 2 trial aims to evaluate the benefit of abatacept (Orencia) treatment in relatives of type 1 diabetes mellitus (T1DM) patients that are at a high risk of developing the disease. The main outcome investigated is whether abatacept will prevent or delay the occurrence of Abnormal glucose tolerance.

These guidelines presented recommendations for lifestyle management in people with diabetes. It was determined that diabetes self-management education and support (DSMES), nutrition therapy, physical activity, stopping smoking, and caring for emotional wellbeing are needed.